Featured Insights and Perspectives from Darwin
The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News and Insights
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Results 1
Date
October 30, 2023
Our Take: Feature: Looking ahead, leading drugmakers will focus on innovation within their existing areas of specialty
Learn More
October 30, 2023
Digital health and emerging technologies
.jpg)
November 6, 2023
Our Take: Drugstore chains claim ‘Pharmageddon’ had minimal impact on stores, say they’re listening to workers
Learn More
November 6, 2023
Pharmacy, PBMs and drug pricing
November 13, 2023
Our Take: Lilly scores FDA approval of tirzepatide for weight management, intensifying rivalry with Novo Nordisk
Learn More
November 13, 2023
Pharma strategy, engagement, and market access
November 20, 2023
Our Take: Vertex, CRISPR Therapeutics gain first-ever approval of CRISPR-based gene-edited therapy
Learn More
November 20, 2023
Pharma strategy, engagement, and market access
December 4, 2023
Our Take: AbbVie to acquire ImmunoGen for $10 billion, adding ADC for ovarian cancer to its portfolio
Learn More
December 4, 2023
IDN trends, challenges, and leadership
.jpg)
December 11, 2023
AbbVie announces another multibillion dollar acquisition, while Roche jumps into the GLP-1 rivalry
Learn More
December 11, 2023
IDN trends, challenges, and leadership
December 18, 2023
2023 In Review: More multibillion-dollar acquisitions, early AI use, a historic drug approval, and more
Learn More
December 18, 2023
Digital health and emerging technologies
January 8, 2024
Merger updates: Several regional mergers are completed, one is called off, and a new one is proposed
Learn More
January 8, 2024
IDN trends, challenges, and leadership
January 15, 2024
Our Take: Novartis takes a pass on acquiring Cytokinetics during a week of Big Pharma deals
Learn More
January 15, 2024
Pharma strategy, engagement, and market access
January 22, 2024
Our Take: General Catalyst’s HATCo selects Summa Health as its intended ‘blueprint’ for transforming health care
Learn More
January 22, 2024
IDN trends, challenges, and leadership
January 29, 2024
Our Take: Financial distress fueled increase in hospital and health system M&A activity in 2023, report indicates
Learn More
January 29, 2024
IDN trends, challenges, and leadership
February 5, 2024
Our Take: Cigna agrees to sell its Medicare business to HCSC for $3.7 billion
Learn More
February 5, 2024
Health policy, CMS initiatives and health economics
Stay Aware. Stay Informed.
Want to stay ahead of health care trends?
Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
